Our Leadership
Our leadership team blends deep immunology, translational science and real‑world biotech operating experience, united by a simple ambition: to turn a breakthrough VLP platform into everyday medicines that are affordable, durable and easy to use.
Jamie Hodgson
Chief Executive Officer
Dr Daniel Galbraith
Non-Executive Chairman
David Lawrence
Non-Executive Director
Dr Kenny Pallas
Commercial Director
Dr Mark Fife
Director - Preclinical Development
Join Our Team
Scientific advisors
-

Professor David Onions
SCIENTIFIC ADVISOR
-

Dr John Foerster
SCIENTIFIC FOUNDER
-

Professor Alan Irvine
CLINICAL ADVISOR